A clinical study showed that a vaccine being developed by GlaxoSmithKline Plc and MedImmune Inc. was 100% effective at preventing infection from the most serious strains of human papillomavirus, which are associated with cervical cancer. Because they are taken once, vaccines aren’t blockbusters, but we think they’re important. We talk about why.
